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Abstract 
 
The aim of this study was conducted to evaluate the effect of Gundelia tournefortii on some biochemical parameters in 
hyperglycemic and hyperlipidemic mice. Male albino mice were induced hyperglycemic and hyperlipidemic by daily injection 
of dexamethasone 1 mg/kg of body weight intramuscularly (i.m.), the mice randomly divided into five groups (6-8 mice in 
each group). The group 1: served as negative control group; the group 2: injected with dexamethasone at dose 1 mg 
/kg.b.w.i.m and served as positive control group; the groups 3, 4, 5: treated with extract of G. tournefortii at doses: 75, 150, 
300 mg/kg.b.w. orally respectively companied with injection of dexamethasone 1 mg/kg.b.w.i.m. All treatment were once 
daily for 22 days. Dexamethasone treatment lead to significant increase in levels of glucose, cholesterol, and triglyceride, and 
significant decrease of body weight, without any effect on level of total protein. G. tournefortii extract treatment at doses: 75 
mg/kg.b.w. resulted significant decrease levels of glucose, and body weight. Beneficial effect were seen when mice treated 
with  G. tournefortii at dose of 300 mg/kg.b.w. that lead to significant decrease in levels of glucose, triglyceride, and 
cholesterol. These results indicate the usefulness of G. tournefortii extract as hypoglycemia and hypolipidemia in 
dexamethasone treated mice.  
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بوعكلا تابنل يئاملا صلختسملا ريثأت يف     ةيتايحلا ةيئايميكلا ميقلا ضعب  دنع  نوھدلاو زوكولكلا طرف
 نوزاثيماسكدلاب ثدحتسملا نارئفلا يف   
  
زيزع نسح رمع
١ و  ردخ وديع فطاع 
٢   
 
١ ةيرھجملا ءايحلأاو ضارملأا عرف   ، يرطيبلا بطلا ةيلك  ،
٢ ةيساسلأا مولعلا عرف   ، ةعارزلا ةيلك    باغلاو تا  ، كوھد ةعماج ، كوھد   ، قارعلا   
 
خلا ةصلا  
 
 بوعكلا تابنل يئاملا صلختسملا ريثأت مييقتل ةساردلا هذھ براجت تممص Gundelia tournefortii   يف    ضعب تايوتسم  ةيئايميكلا ميقلا
نوھدلاو زوكولكلا ةعفترملا نارئفلا يف ةيتايحلا  . نم نارئف روكذ تمدختسا ُ    عون Albino  تسم عفرل ايبيرجت ً  مدلا موحشو زوكولكلا تايو
ةعرجب ةلضعلاب نوزاثيماسكدلا ةدامب ايموي اھنقحب ً   ١ مغلم  / مسجلا نزو نم مغك  .  عيماجم ةسمخ ىلإ ايئاوشع نارئفلا تمسق ً )  ةعومجم لك
٦ - ٨ نارئف  :( ىلولأا ةعومجملا  : ةيناثلا ةعومجملا ،ةميلس ةرطيس ةعومجمك ةلماعم نود تكرت  : ب نوزاثيماسكدلا ةدامب تنقح  ةلضعلا
ةعرجب   ١ مغلم  /  عيماجملا ،ةباصم ةرطيس ةعومجمك تدعو مسجلا نزو نم مغك ُ ٣  ، ٤  ، ٥  ، صلختسملا اھئاطعإ مت    يئاملا  بوعكلا تابنل G. 
tournefortii عرجلابو  ُ  : ٧٥  ، ١٥٠  ، ٣٠٠ مغلم  /  بيترتلا ىلع مسجلا نزو نم مغك مفلا قيرط نعو  ةدامب اھنقح عم   سفنب نوزاثيماسكدلا
هلاعأ ةعرجلا .  ةدملو مويلاب ةدحاو ةرمل تناك تلاماعملا لك  ٢٢ موي   .  تدأ  تايوتسم يف يونعم عافترا ىلإ نوزاثيماسكدلاب ةلماعملا
مسجلا نزول يونعم ضفخ عم ،ةيثلاثلا تاديريسيلكلا ،لورتسلوكلا ،زوكولكلا   ةيلكلا تانيتوربلا ىوتسم ىلع ريثأت هل نكي ملو  .  ترھظأ
ةلماعملا جئاتن ملا صلختسملاب   تابنل يئا  بوعكلا G. tournefortii عرجلابو   ة ٧٥ مغلم  /  يف يونعم ضافخنا ىلإ مسجلا نزو نم مغكIraqi Journal of Veterinary Sciences, Vol. 26, No. 2, 2012 (73-79) 
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 تايوتسم مسجلا نزوو ،زوكولكلا  .  تابنل يئاملا صلختسملا مادختسا دنع ظحول لضفلأا ريثأتلا  بوعكلا G. tournefortii  ةعرجلاب  ٣٠٠  
مغلم  / وتسمل يونعم ضفخ ىلا تدأ ثيح مسجلا نزو نم مغك ،زوكولكلا تاي لورتسلوكلاو ،ةيثلاثلا تاديريسيلكلا   .  ةساردلا جئاتن ريشت
 تابن نأ ىلإ ةيلاحلا  بوعكلا G. tournefortii  ضفخ يف ارود كلتمي  ً نوزاثيماسكدلاب نارئفلا ةلماعم دنع مدلا موحشو ،زوكولكلا تايوتسم .    
 
 
Introduction 
 
Diabetes mellitus is a metabolic disorder characterized 
by resistance to the action of insulin, insufficient secretion, 
or both (1). The major clinical manifestation of the diabetes 
state is hyperglycemia, however, insulin deficiency and/or 
insulin resistance also are associated with disturbance in 
lipid and protein metabolism (2). WHO indicates that 
diabetes mellitus is one of the major killers of humans in 
our time (3). Management of diabetes without any side 
effect is still a challenge to the medical system, this had led 
to an increasing demand for natural products with 
antidiabetic activity and fewer side effects (4).  
Dexamethasone a synthetic glucocorticoids and a wide 
spread anti-inflammatory drug, and induce a decrease in 
insulin sensitivity (5), or insulin resistance and an elevation 
in the level of serum glucose and lipids (6). So this drug is 
used for the induction of hyperglycemia and hyperlipidemia 
in mice and rats as model for type -2 diabetes mellitus (7,8).  
Throughout history, humans have derived many uses 
and benefits from the plants found in their own region (9). 
Gundelia tournefortii GT  (kuub; Arabic and kanger; 
Kurdish names) from the Asteraceae (compositae) family. 
It is an nature born plant, native to Asian – temperate zones 
of western Asia, manly Cyprus, Egypt, Jordan, Turkey, 
Azerbaijan, Turkmenistan and Iraq, its leaves, seeds and 
stems are used as food sources (10). It is recorded that the 
water extracts of G. tournefortii roots were containing 
phenols, glycosides, tannins, flavonoids, carbohydrates, 
proteins, alkaloids and nitrate (11,12), and saponins (13). It 
is used to enhance gingivas and as an appetizer (14), also 
fresh seeds of it are used in pikles and also are effective 
diuretics (15), and inhibition of α-amylase activity (16). 
G,tournefortii also have an effect on platelet aggregation 
(17), and can decrease some cardiovascular risk factors, and 
decrease atherosclerosis (18). This study was conducted to 
evaluate the effects of G,tournefortii roots hot water extract 
in dexamethasone induced hyperglycemic and 
hyperlipidemic mice.  
 
Materials and methods 
 
Plant materials:  
Naturally grown G. tournefortii plants were bought 
from vegetable market in Duhok city. The plant was 
classified at faculty of Agriculture and forestry / Duhok 
University, fresh roots were used in this study.  
 
Plant extract 
Boiled water extract was prepared by weighing and 
cutting up a certain weight of plant roots into small pieces, 
plant pieces were put in conical flask and submerged by 
1cm of distilled water, the mixture heated in shaking water 
bath at 95C
◦ for 30 minutes (19).The mixture was filtrated 
though a piece of cotton and several layers of gauze which 
put on the funnel mouth and left for 24 hr to complete the 
filtration process and the filtrate stored in dark bottles in the 
freezer. Dry matter was 0.56 gm per 50 ml of extract which 
is determined by using (Freeze dryer with shell freezer-
LFD-55085-Daihan lab tech Co. LTD Korea).  
 
Animals  
Male albino mice weighing between 24.6 and 33.2 gm 
were procured from Veterinary college /Duhok University, 
they were housed under standard conditions of temperature 
(22 ±3C
◦) with a 14:10 dark light cycle. The animals were 
fed with standard diet and water ad libitum.  
  
Induction of hyperglycemia 
Dexamethasone sodium phosphate ampoules 
concentration 8 mg/2 ml (H-tech international enterprises 
Co.ltd) were used for inducing hyperglycemia at a dose (1 
mg/kg of body weight intramuscularly diluted by normal 
saline and volume of injection was 5 ml/kg.b.w.) daily for 
22 days (7).  
  
Experimental design 
Animals randomly were divided into five groups, each 
consisting of 6-8 mice. Group 1: Served as negative control 
group; Group 2: received dexamethasone 1.0 mg/kg of 
body weight and served as positive control group; Group 3: 
treated with dexamethasone 1.0 mg/kg of body weight. plus 
plant extract containing dry matter 75 mg/kg of body 
weight; Group 4: received dexamethasone 1.0 mg/kg of 
body weight plus plant extract containing dry matter 150 
mg/kg of body weight; Group 5: treat with dexamethasone 
1.0 mg/ kg of body weight plus plant extract containing dry 
matter 300 mg/kg of body weight.  
Dexamethasone were given by intramuscular rout and 
volume of injection 5 ml/kg., While G. tournefortii extract 
were given orally at 5 ml/kg.b.w. by gavages needle. All 
treatment was once daily and lasted for 22 days.  
 
Sample collection  
Blood samples were collected at zero,11 and 22 days 
after overnight fasting from the orbital plexus of vein into Iraqi Journal of Veterinary Sciences, Vol. 26, No. 2, 2012 (73-79) 
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clean dry centrifuge tubes allowed to clot, serum was 
separated after centrifugation at 1500 rpm for 15 minutes 
(20), Glucose, total cholesterol, triglyceride and total 
protein were estimated calorimetrically using (Biolabo 
standard kits, France).  
  
Statistical analysis  
All data analyzed by one way analysis of variance, the 
specific group differences were determined using duncan 
multiple range test; the accepted level of significance was 
P<0.05 (21).  
  
Results 
 
As shown from table 1 the results reflect the effect of 
dexamethasone treating alone or in combination with 
different doses of G. tournefortii extract on the body weight 
in mice, the results show that dexamethasone causes a 
significant decrease in body weight after 22 days when 
compared with zero time in the same group, also 
dexamethasone combination with G. tournefortii extract 
causes significant decrease in body weight in dose 75 
mg/kg.b.w. when compare with dexamethasone treated 
group, and the doses 150 and 300 mg /kg.b.w lead to 
significant decrease in body weight when compared with 
zero time in same groups. 
  
Table (1): Effect of Gundelia tournefortii extract on body 
weight (g) in  dexamethasone treated mice. 
 
Time 
22 days  11 days  Zero 
Groups 
BCD 
28.58 
±1.028 
B 
29.81 
±1.43 
BC 
29.68 
±1.521 
Normal 
D 
27.06 
±0.537 
BCD 
27.72 
±0.627 
BC 
29.64 
±0.564 
Dexamethasone 1 
mg/kg.b.w.i.m  
E 
24.51 
±0.723 
D 
26.77 
±0.963 
CD 
27.2 
±0.73 
Dexamethasone 1 
mg/kg.b.w.i.m + GT 
75 mg/kg.b.w.orally 
BCD 
27.33 
±0.724 
BCD 
29.23 
±0.276 
A 
32.2 
±0.428 
Dexamethasone 1 
mg/kg.b.w.i.m + GT 
150 mg/ kg.b.w. orally 
BCD 
28.26 
±0.31 
B 
29.75 
±0.588 
A 
32.05 
±0.461 
Dexamethasone 1 
mg/kg.b.w.i.m + GT 
300 mg/ kg.b.w. orally 
No. of mice (6-8) in each group, Data is the mean ± SEM. 
Different letters indicate significant differences between 
groups horizontally and vertically at P < 0.05.  
 
Table 2 is indicating that dexamethasone treatment 
causes a significant increase in serum glucose level in mice 
when compared with the normal group,also the table show 
that treatment with G. tournefortii extract at doses 75,150, 
300 mg/kg b.w. causes a significant decrease in glucose 
level when compared with dexamethasone treated group,the 
more significant effect was in the group of mice which 
received 75, 300 mg/kg.b.w. after 22 days and it was close 
to the normal level. 
 
Table (2): Effect of Gundelia tournefortii extract on serum 
glucose level (mg/dl) in dexamethasone treated mice.  
 
Time 
22 days  11 days  Zero 
Groups 
DE 
179.91 
±6.033 
DE 
185.91 
±3.084 
DE 
182.45 
±5.026 
Normal 
A 
261.76 
±8.123 
C 
210.29 
±3.934 
DE 
188.01 
±4.505 
Dexamethasone 1 
mg/kg.b.w.i.m  
E 
170.24 
±8.399 
CD 
193.01 
±8.188 
DE 
189.28 
±4.824 
Dexamethasone 1 
mg/kg.b.w.i.m + GT 
75 mg/kg.b.w.orally 
B 
229.29 
±7.955 
DE 
186.56 
±6.697 
DE 
190.42 
±4.706 
Dexamethasone 1 
mg/kg.b.w.i.m + GT 
150 mg/ kg.b.w. orally 
DE 
184.87 
±6.502 
DE 
182.72 
±4.742 
DE 
187.95 
±3.485 
Dexamethasone 1 
mg/kg.b.w.i.m + GT 
300 mg/ kg.b.w. orally 
No. of mice (6-8) in each group, Data is the mean ± SEM. 
  Different letters indicate significant differences between 
groups horizontally and vertically at P < 0.05. 
 
The results in table 3 show that dexamethasone treating 
in mice cause a significant elevation in the serum 
triglyceride level when compared with the normal 
group,but in the groups that received G. tournefortii extract 
doses 150,300 mg/kg.b.w. there was a significant reduction 
in serum triglyceride level after 22 days of treatment when 
compared with dexamethasone treated group. 
The level of total serum cholesterol as shown in table 4 
were increased in the group of mice which received 
dexamethasone when compared with the normal, also this 
table indicates that treatment with G. tournefortii extract 
cause a reduction in serum cholesterol levels after 11 days 
in the group that received 75 mg/kg B.W. and at 11,22 days 
of treatment in the other groups when compared with 
dexamethasone treated group, the more significant result 
was in the group of mice which received 300 mg/kg b.w. of 
the extract. 
 There is no significant changes in serum total protein level 
in dexamethasone treated group when compared with the 
normal group,also in the groups of mice which treated with 
all doses of G. tournefortii (Table-5). 
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Table (3): Effect of Gundelia tournefortii extract on serum 
triglyceride level (mg/dl) in dexamethasone treated mice. 
 
Time 
22 days  11 days  Zero 
Groups 
CDE 
139.95 
±3.848 
DE 
136.35 
±4.725 
CDE 
140.84 
±5.295 
Normal 
A 
188.03 
±2.971 
BC 
156.17 
±4.126 
CDE 
143.64 
±4.973 
Dexamethasone 1 
mg/kg.b.w.i.m  
B 
166.09 
±9.184 
BCD 
151.28 
±1.629 
CDE 
141.32 
±6.324 
Dexamethasone 1 
mg/kg.b.w.i.m + GT 
75 mg/kg.b.w.orally 
CDE 
144.25 
±5.164 
CDE 
142.14 
±4.174 
CDE 
145.14 
±5.744 
Dexamethasone 1 
mg/kg.b.w.i.m + GT 
150 mg/ kg.b.w. orally 
E 
133.2 
±6.186 
CDE 
143.26 
±0.309 
CDE 
143.4 
±5.638 
Dexamethasone 1 
mg/kg.b.w.i.m + GT 
300 mg/ kg.b.w. orally 
No. of mice (6-8) in each group, Data is the mean ± SEM. 
Different letters indicate significant differences between 
groups horizontally and vertically at P < 0.05. 
 
Table (4): Effect of Gundelia tournifortii extract on serum 
total cholesterol level (mg/dl) in dexamethasone treated 
mice.  
 
Time 
22 days  11 days  Zero 
Groups 
C 
228.99 
±7.512 
BC 
230.93 
±3.124 
BC 
235.42 
±16.481 
Normal 
A 
334.11 
±14.04 
A 
305.85 
±14.703 
BC 
240.45 
±14.826 
Dexamethasone 1 
mg/kg.b.w.i.m  
A 
333.15 
±14.843 
BC 
233.04 
±8.803 
BC 
231.39 
±9.433 
Dexamethasone 1 
mg/kg.b.w.i.m + GT 
75 mg/kg.b.w.orally 
B 
269 
±14.375 
C 
212.77 
±9.334 
BC 
237.03 
±11.837 
Dexamethasone 1 
mg/kg.b.w.i.m + GT 
150 mg/ kg.b.w. orally 
C 
226.02 
±9.449 
C 
212.71 
±10.104 
BC 
238.57 
±11.704 
Dexamethasone 1 
mg/kg.b.w.i.m + GT 
300 mg/ kg.b.w. orally 
Data is the mean ± SEM, Different letters indicate 
significant differences between groups horizontally and 
vertically at P < 0.05. 
 
Discussion 
 
The present study demonstrated that dexamethasone 
treatment produced a significant decrease in body weight 
when compare with zero time, this result agree with other 
studies in normal rats (22,23). This may be due to that 
dexamethasone stimulate production of myostatin leading 
to muscle atrophy and decrease of body weight (22), (23) 
reported that dexamethasone have an ability to decrease 
body weight by prevent enter of glucose to the cells leading 
to loss of calories. 
Dexamethasone produced significant increases in serum 
glucose, and this result agree with (5,7,24,25) in mice, and 
(8) in rats, but disagree with (26) in rats. The increase of 
serum glucose level may be due to decrease insulin-
stimulated glucose uptake in muscle (27), or 
dexamethasone disrupts insulin-mediated recruitment of 
glucose transporters at the cell surface (28,29). Also 
dexamethasone stimulate gluconeogenesis in liver cells by 
stimulate glucose-6-phosphatase (30,31). 
Dexamethasone lead to significant increase in serum 
cholesterol, similar result reported by (32) in normal and 
diabetic rats, and disagree with (33) in human. The increase 
of serum cholesterol level may be due to that 
dexamethasone inhibit nitric oxide synthesis which have a 
role in regulation of lipid levels in blood (26). 
 
Table (5): Effect of Gundelia tournifortii extract on serum 
total protein (g/dl) in dexamethasone treated mice. 
 
Time 
22 days  11 days  Zero 
Groups 
ABC 
5.73 
±0.112 
BC 
5.51 
±0.048 
ABC 
5.66 
±0.164 
Normal 
C 
5.45 
±0.186 
ABC 
5.73 
±0.239 
ABC 
5.65 
±0.176 
Dexamethasone 1 
mg/kg.b.w.i.m  
C 
5.29 
±0.176 
AB 
6.07 
±0.308 
BC 
5.55 
±0.165 
Dexamethasone 1 
mg/kg.b.w.i.m + GT 
75 mg/kg.b.w.orally 
BC 
5.5 
±0.276 
ABC 
5.84 
±0.147 
BC 
5.57 
±0.139 
Dexamethasone 1 
mg/kg.b.w.i.m + GT 
150 mg/ kg.b.w. orally 
C 
5.29 
±0.063 
A 
6.17 
±0.139 
ABC 
5.61 
±0.16 
Dexamethasone 1 
mg/kg.b.w.i.m + GT 
300 mg/ kg.b.w. orally 
No. of mice (6-8) in each group, Data is the mean ± SEM. 
  Different letters indicate significant differences between 
groups horizontally and vertically at P < 0.05  
 
Triglyceride levels also increased significantly when we 
use dexamethasone to induce hyperglycemia and 
hyperlipidemia, (8,34) reported similar results in rats, and 
(35) in human. This may be due to that dexamethasone 
stimulate production and secretion of lipoproteins mainly 
very low density lipoprotein from liver that rich in 
triglyceride (36), or may dexamethasone cause insulin Iraqi Journal of Veterinary Sciences, Vol. 26, No. 2, 2012 (73-79) 
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resistance which decrease effect of insulin on liver and 
adipose tissue leading to secret triglyceride from liver and 
prevent ability of tissue to remove lipoproteins from blood 
(37). 
In our study, treatment mice with G. tournefortii leads 
to significant decrease in serum glucose levels in all three 
doses when compare with dexamethasone group. The 
possible mechanism is due to presence of flavonoide in it 
(11) which stimulate secretion of insulin from pancreas 
leading to increase its level in blood (38), or flavonoide 
may increase the insulin sensitivity (39), also flavonoide 
activated peroxisoe-proliferator-activated-receptor (PPAR) 
that regulate the transcription of gene involved in lipid and 
glucose homeostasis and metabolism within the cell (40), 
this effect of flavonoide may be like flavonoide of soybean 
(38). Also may flavonoide of G. tournefortii decrease 
glucose absorption from intestine through decrease 
processes of glucose transports depended on calcium (41), 
flavonoide can acts as antioxidant by increasing antioxidant 
enzymes (42), similar observation reported by (43) when 
flavonoide of trifolium alexandrium acts as antioxidant in 
streptozotasin induced diabetic rats. 
Also decreases of serum glucose level may be due to 
inhibition of α-amylase by G. tournefortii (16) that found in 
saliva and pancreatic secretions which degrade starch first 
to oligosaccharide and then to maltose and glucose, (44) 
that phaseolus acutifolius A. Gray, pistacia atlantica, and 
paranychia argentea have hypoglycemic activity through 
α-amylase inhibition. as wall as may the hypoglycemic 
activity of G. tournefortii is due to presence of sterol in it 
(17) and in study of (45) shown that extract of Anacandina 
occidentale that contain sterols cause significant decrease in 
blood glucose level in normal dogs, and (46) referred that 
sterol presence in extraction of centaure serdis 
L.varmentime lge leaves cause significant decrease of blood 
glucose level in rats. Sterol acts by increase blood insulin 
levels through stimulation its secretion from β-cells in 
pancreas (47). 
A significant decrease in blood serum cholesterol levels 
was observed in G.tournefortii  treatment in 150,300 
mg/kg.b.w. and this results agree with (18) in rabbit. 
Possible explanation of lowering cholesterol is may due to 
presence of flavonoids that have antioxidant and 
hypolipidemic activity which act by inhibition of 
lipoprotein oxidation and increasing low density lipoprotein 
receptor activity (48), similar result showed by (49) in mice 
when treated by soybean seeds that contain flavonoide. 
Also may be the lowering of cholesterol levels due to 
presence of saponin in G. tournefortii (13) report that 
treatment by seeds of fenugreek that contain saponin lowers 
cholesterol levels in human with type 2 diabetes. The effect 
of saponin may be due to hydrolysis of saponin to 
sapogenin in gastrointestinal tract which stimulate secretion 
of bile acids by liver, also saponin decrease absorption of 
cholesterol in intestine (50), or effect of saponin may due to 
stimulate liver to convert cholesterol to bile acids (51). The 
other mechanisms of lowering cholesterol is that sterol of 
G. tournefortii (17) acts to decrease estrification of 
cholesterol in gastric cells and reveres the unestrified 
cholesterol again to intestine (52). 
Significant decrease of blood triglyceride levels were 
observed in mice treated with G.tournefortii, our result 
agree with (18) in rabbit, the decrease of blood triglyceride 
levels may due to flavonoide of G. tournefortii have 
antioxidant effect that increase insulin's activity as 
hypolipidemic (53), or flavonoide may affect in cellular 
lipid homeostasis by the down regulation of sterol-
regulatory-element-binding-protein (SREBP) and its target 
genes in the liver which are involved in the synthesis of 
triglyceride (54). 
All treatment doses of G.tournefortii  with 
dexamethasone lead to significant decrease of body weight 
when compare with zero time in same group, our result may 
be due to the non significant lowering of serum total protein 
level. The decrease in body weight observed might be the 
result of protein wasting due to unavailability of 
carbohydrate for utilization as an energy source (55).  
Our study indicate the usefulness of G. tournefortii 
extract as hypoglycemia and hypolipidemia in 
dexamethasone treated mice.  
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